Essential Thrombocythemia with Acquired von Willebrand’s Disease
Open Access
- 1 July 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 88 (1) , 102-106
- https://doi.org/10.1093/ajcp/88.1.102
Abstract
Two patients with essential thrombocythemia showed a marked decrease in ristocetin-induced platelet aggregation in addition to other aggregation defects during routine aggregation studies for prolonged bleeding times. Further investigation revealed type I von Willebrand’s disease (vWD) in one patient and a variant of vWD compatible with type IIA defect in the second patient. The latter patient had minor episodes of epistaxis clinically, while the patient with type I disease experienced excessive blood loss during menstrual periods. Both patients gave negative history for abnormal bleeding in the past or in their families. Both have had uneventful surgical procedures in the past, at which time bleeding times and basic coagulation test results were normal.Keywords
This publication has 5 references indexed in Scilit:
- STUDIES OF THE PATHO-PHYSIOLOGY OF ACQUIRED VONWILLEBRANDS DISEASE IN 7 PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS OR BENIGN MONOCLONAL GAMMOPATHIES1984
- ACQUIRED VONWILLEBRANDS DISEASE IN THE MYELOPROLIFERATIVE SYNDROME1984
- Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four casesBritish Journal of Haematology, 1983
- Acquired von Willebrand's DiseaseNew England Journal of Medicine, 1978
- Acquired von Willebrand’s Syndrome in Systemic Lupus ErythematosusBlood, 1968